Abstract

Benorylate (Benoral - Winthrop), Safapryn (Pfizer) and Levius (Pharmitalia) are ingenious new preparations for giving aspirin, intended for the treatment of chronic rheumatic disorders and mild to moderate pain from many causes. They are claimed to have analgesic and anti-inflammatory effects comparable with ordinary aspirin, with little risk of gastric irritation and bleeding. They thus need to be considered together with enteric-coated aspirin. Benoral and Levius are said to produce prolonged elevation of plasma salicylate concentrations after oral dosage, so that twice daily medication suffices.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.